Commensal Microbiota Promote Lung Cancer Development via γδ T Cells-Reference-Cited by-同舟云学术

Commensal Microbiota Promote Lung Cancer Development via γδ T Cells

Published:2019-02 Issue:5 Volume:176 Page:998-1013.e16
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Jin Chengcheng,Lagoudas Georgia K.,Zhao Chen,Bullman Susan,Bhutkar Arjun,Hu Bo,Ameh Samuel,Sandel Demi,Liang Xu Sue,Mazzilli Sarah,Whary Mark T.,Meyerson Matthew,Germain Ronald,Blainey Paul C.,Fox James G.,Jacks Tyler

Funder

Helen Hay Whitney Foundation-Merck

Margaret A. Cunningham Immune Mechanisms in Cancer Research

National Cancer Institute

Broad’s Next10 Award

Hugh Hampton

NCI

CRI

Department of Defense

Howard Hughes Medical Institute

Broad Institute

Burroughs Wellcome Fund

NHLBI

NIAID, NIH

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference61 articles.

1. Infectious complications in patients with lung cancer;Akinosoglou;Eur. Rev. Med. Pharmacol. Sci.,2013

2. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs;Altschul;Nucleic Acids Res.,1997

3. Intravascular staining for discrimination of vascular and tissue leukocytes;Anderson;Nat. Protoc.,2014

4. IL-17A-producing T cells are associated with the progression of lung adenocarcinoma;Bao;Oncol. Rep.,2016

5. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1;Barbie;Nature,2009

Cited by 659 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibiotic-loaded nanoparticles for the treatment of intracellular methicillin-resistant Staphylococcus Aureus infections: In vitro and in vivo efficacy of a novel antibiotic;Journal of Controlled Release;2024-10

2. Pharmacomicrobiomics in precision cancer therapy: bench to bedside;Frontiers in Immunology;2024-09-09

3. Microbiome-Mucosal Immunity Nexus: Driving Forces in Respiratory Disease Progression;Journal of Microbiology;2024-09-06

4. The gut microbiome modulate response to immunotherapy in cancer;Science China Life Sciences;2024-09-02

5. Relevance of harmful intratumoral microbiota in cancer progression and its clinical application;Biomedicine & Pharmacotherapy;2024-09